维普中文期刊产品整合服务
58篇 您的检索式:作者名="Passant"
    题名 作者 年代 出处 被引量
1羊膜移植治疗睑球黏连的临床观察(英文)显示文摘目的:评估羊膜移植(AMT)在治疗睑球黏连中的应用效果。方法:这项无对照干预性病例研究于2013/01~2015/12,包括连续就诊的12名患者共14眼。患者均接受永久性羊膜移植,以治疗睑球黏连,使用冷冻保存或冷冻干燥的羊膜(AM)。这12例(14眼)患者,年龄在26~62岁,平均43.38±11.25岁,其中8例(4名男性,4名女性)10眼为翼状胬肉切除术后继发,4例患者(1名男性,3名女性)斜视手术后继发。所有患者距上次手术至少6mo。术后以恢复深度稳定的穹窿为手术成功,无瘢痕或炎症发生,6mo的随访期间无眼球运动的限制。结果:随访期平均为7±4.2mo(6-9mo)。在所有14只眼中,手术后3wk均观察到AM完全上皮化,手术部位无炎症表现。总共14眼中有8眼(成功率57%)显示穹窿重建成功,穹窿深,无复发。有4眼(29%)表现出部分成功,中度深度的穹窿和中度瘢痕。有2眼(14%)显示重建失败,穹窿完全闭合。有7眼手术后视力改善,7眼视力保持稳定。AMT术后并发症少,14眼中1眼(7%)发生严重的结膜反应和眼球运动受限。而在术后前3mo中,14眼中有2眼发生化脓性肉芽肿(14%),予以手术切除,局部糖皮质激素注射。结论:单用AMT是一种治疗睑球黏连安全有效的方法。考虑到与角膜缘切除有关的潜在不良反应,AMT也是一种有效的重建穹窿以修复各种眼表疾病所致睑球黏连的方法。Ahmed Tamer Sayed Saif Passant Sayed Saif Amr El Deeb 2017国际眼科杂志2017,17,5:4
2RBL-2H3 cells are an imprecise model for mast cell mediator release显示文摘Passante E Ehrhardt C Sheridan H 2009Inflamm Res2009,58,9:1
3Proteasome inhibi- tion can induce an autophagy-dependent apical activation of caspase- 8 显示文摘Laussmann MA Passante E Dussmann H 2011Cell Death Differ2011,18,10:1
4RBL-2H3 cells are an imprecise model for mast cell mediator release 显示文摘Passante E Ehrhardt C Sheridan H 2009Inflamm Res2009,58,9:1
5Stability in the clinical characteristics of patients with memory complaints 显示文摘Vestberg S Passant U Elfgren C 2010Arch Gerontol Geriatr2010,50,3:1
6The Molecular Machinery Regulating Apoptosis Signal Transduction and its Implication in Human Physiology and Pathophysiologies显示文摘C. T. Hellwig E. Passante M. Rehm 2011Current Molecular Medicine2011,,:1
7RBL-2H3 cells are an im- precise model for mast cell mediator release 显示文摘Passante E Ehrhardt C Sheridan H 2009lnflamm Res2009,58,:1
8Cerebral amyloid angiopathy and cortical micro infarcts as putative substrates of vascular dementia显示文摘Haglund M Passant U Sjobeck M 2006Int J Geriatr Psychiatry2006,21,7:1
9Regional cerebral blood flow and EEG in clinically diagnosed dementia with Lewy bodies and Alzheimer's disease显示文摘Londos E Passant U Brun A 2003Arch Gerontol Geriatr2003,36,3:1
10RBL-2I-I3 cells are an imprecise model for mast cell mediator release 显示文摘Passante E Ehrhardt C Sheridan H 2009Intlamm IRes2009,58,9:1
11RBL-2H3 cells are an impreeise model for mast cell mediator release显示文摘Passante E Ehrhardt C Sheridan H 2009In- flamm Res2009,58,:1
12Prevalence of thyroid hormone abnormalities in elderly patients with symptoms of organic brain disease显示文摘R. F?ldt U. Passant K. Nilsson C. Wattmo L. Gustafson 1996Aging Clinical and Experimental Research1996,,5:1
13Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria显示文摘D. Neary J. S. Snowden L. Gustafson U. Passant D. Stuss S. Black M. Freedman A. Kertesz P. H. Robert M. Albert K. Boone B. L. Miller J. Cummings D. F. Benson 1998Neurology1998,,:1
14RBL-2H3 cells are an imprecise model for mast cell mediator release显示文摘Passante E Ehrhardt C Sheridan H 2009Inflamm Res2009,58,9:1
15A clinico-pathological study of heart and brain lesions in vascular dementia显示文摘Andin U Gustafson L Passant U 2005Dement Geriatr Cogn Disord2005,19,:1
16Toll-like rece- ptors and RBL-2H3 mast cells显示文摘Passante E Ehrhardt C Sheridan H 2009Inflamm Res2009,,:1
17The RBL-2H3 cell line : itsprovenance and suitability as model for the mast cell显示文摘Egle Passante Neil Frankish 2009Inflamm Res2009,58,:1
18Meaning of A Tag:A Collaborative Approach to Bridge the Gap Between Tagging andLinked Data显示文摘Passant A Laublet P 0,,41:1
19RBL-2H3 cells are an imprecise model for mast cell mediator release 显示文摘PASSANTE E EHRHARDT C SHERIDAN H 2009Inflamm Res2009,58,9:1
20RBL-2H3 cells are an imprecise model for mast cell mediator release显示文摘Passante E Ehrhardt C Sheridan H 2009In- flamm Res2009,58,9:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费